Sandra M. Gurrola
CIK: 0001618457
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (50.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ERNA
Eterna Therapeutics Inc.
Officer
Discretionary Trading P&L
Holdings
About Gurrola Sandra M
Gurrola Sandra M (SEC CIK 0001618457) files insider reports with the SEC as Sr. VP of Finance of Eterna Therapeutics Inc. (ERNA).
Signal8 holds 2 ownership filings by Gurrola Sandra M, all Form 4s, filed between Feb 10, 2025 and Jul 7, 2025. Those filings report 2 transactions, from Feb 7, 2025 to Jun 21, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Gurrola Sandra M's filings is in CAMBRIDGE, MA.
Recent filings by Gurrola Sandra M
Other insiders filing for Eterna Therapeutics Inc. (ERNA)
- Spiegel Robert J., Director
- Bristol James Arthur, Director
- Cicala Peter, Director
- Polinsky David, Director
- Wexler William A., Director
- Ratner Elena, Director